Kiora Pharmaceuticals, Inc.
KPRX
$2.10
$0.2111.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.38M | 20.67M | 24.11M | 26.79M | 29.04M |
| Total Receivables | 2.67M | 3.11M | 2.06M | 871.40K | 2.15M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 205.70K | 210.80K | 213.00K | 2.04M | 175.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 444.70K | 746.30K | 728.60K | -- | 294.60K |
| Total Current Assets | 22.69M | 24.74M | 27.11M | 29.71M | 31.65M |
|
|
|||||
| Total Current Assets | 22.69M | 24.74M | 27.11M | 29.71M | 31.65M |
| Net Property, Plant & Equipment | 419.80K | 455.90K | 157.10K | 62.40K | 135.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 0.00 | 6.69M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.75M | 6.75M | 6.76M | 6.72M | 34.40K |
| Total Assets | 29.86M | 31.95M | 34.02M | 36.48M | 38.51M |
|
|
|||||
| Total Accounts Payable | 241.50K | 282.50K | 942.50K | 415.60K | 660.40K |
| Total Accrued Expenses | 2.15M | 1.62M | 1.07M | 2.26M | 1.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 155.90K | 143.30K | 71.60K | 23.40K | 33.40K |
| Total Finance Division Other Current Liabilities | 29.10K | 1.14M | 3.20M | 3.31M | 1.27M |
| Total Other Current Liabilities | 29.10K | 1.14M | 3.20M | 3.31M | 1.27M |
| Total Current Liabilities | 2.58M | 3.19M | 5.27M | 6.01M | 3.53M |
|
|
|||||
| Total Current Liabilities | 2.58M | 3.19M | 5.27M | 6.01M | 3.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 248.20K | 287.10K | 87.50K | 33.80K | 39.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.62M | 6.35M | 4.96M | 4.68M | 4.91M |
| Total Liabilities | 7.45M | 9.82M | 10.32M | 10.72M | 8.48M |
|
|
|||||
| Common Stock & APIC | 170.36M | 170.10M | 169.57M | 169.42M | 169.26M |
| Retained Earnings | -147.70M | -147.73M | -145.58M | -143.38M | -139.16M |
| Treasury Stock & Other | -243.70K | -245.80K | -297.20K | -282.20K | -75.20K |
| Total Common Equity | 22.41M | 22.13M | 23.70M | 25.76M | 30.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 22.41M | 22.13M | 23.70M | 25.76M | 30.03M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.41M | 22.13M | 23.70M | 25.76M | 30.03M |
|
|
|||||